Sanofi (SNY) EBIT Margin (2009 - 2026)
Sanofi (SNY) recorded EBIT Margin of 9.03% in the quarter ended Jun 30, 2026, down 5.71 percentage points from 14.74% a year earlier and down 11.15 percentage points from the prior quarter.
Powered by 
Analysis
Sanofi (SNY) EBIT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Sanofi's EBIT Margin came in at 6.98% as of Jun 30, 2026, down 13.45 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 14.54%, down 3.11 percentage points from the prior year.
- Annual EBIT Margin has declined for three straight years, with a five-year change of -24.62 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, EBIT Margin came in at 17.65% in the year ended Dec 31, 2024 (-0.75 pp), 18.40% in the year ended Dec 31, 2023 (-8.59 pp), 26.99% in the year ended Dec 31, 2022 (+5.47 pp) and 21.52% in the year ended Dec 31, 2021 (-17.64 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBIT Margin since the quarter ended Dec 31, 2024.
- On a year-over-year basis, EBIT Margin rose in two of the last seven quarters, with an average year-over-year change of -16.97 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 111.94 percentage points in the quarter ended Dec 31, 2023, against a drop of 143.10 percentage points in the quarter ended Dec 31, 2021 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Sanofi | 50.28 Bn | 17.06 Bn | 10.79 Bn | 9.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.03% |
| Mar 31, 2026 | 20.18% |
| Sep 30, 2025 | 22.84% |
| Jun 30, 2025 | 14.74% |
| Mar 31, 2025 | 23.09% |
| Dec 31, 2024 | 8.91% |
| Sep 30, 2024 | 29.11% |
| Jun 30, 2024 | 16.25% |
| Mar 31, 2024 | 13.84% |
| Dec 31, 2023 | 122.84% |
| Sep 30, 2023 | 26.84% |
| Jun 30, 2023 | 18.66% |
| Mar 31, 2023 | 24.10% |
| Dec 31, 2022 | 10.90% |
| Sep 30, 2022 | 21.82% |
| Jun 30, 2022 | 14.16% |
| Mar 31, 2022 | 24.78% |
| Dec 31, 2021 | 14.75% |
| Sep 30, 2021 | 29.06% |
| Jun 30, 2021 | 17.60% |
API Access
Sanofi EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();